Skip Navigation
Skip to contents



10 results

Myasthenia Gravis Aggravated by Steroid-Induced Isolated Mediastinal Tuberculous Lymphadenitis

Nam TS, Park MS, Choi KH, Jung HJ, Yoon GJ, Choi SM, Kim BC, Kim MK, Cho KH

  • J Clin Neurol.
  • 2010 Dec;6(4):224-226.
  • doi: 10.3988/jcn.2010.6.4.224
BACKGROUND: Myasthenia gravis (MG) is occasionally aggravated by chronic infection, of which there are many kinds. CASE REPORT: We report herein the case of a 56-year-old woman with MG aggravated by...
Medullary Hemorrhage after Ischemic Wallenberg's Syndrome in a Patient with Cavernous Angioma

Yang HD, Lee KH

  • J Clin Neurol.
  • 2010 Dec;6(4):221-223.
  • doi: 10.3988/jcn.2010.6.4.221
BACKGROUND: The main complication of cerebral cavernous angioma is hemorrhage. Ischemic stroke as a complication of cerebral cavernous angioma has rarely been described, and hemorrhage after ischemic Wallenberg's syndrome has...
Arteriovenous Malformation with an Occlusive Feeding Artery Coexisting with Unilateral Moyamoya Disease

Ahn SH, Choo IS, Kim JH, Kim HW

  • J Clin Neurol.
  • 2010 Dec;6(4):216-220.
  • doi: 10.3988/jcn.2010.6.4.216
BACKGROUND: Arteriovenous malformations (AVMs) with vascular abnormalities, including aneurysms, have been reported frequently. However, the coexistence of AVM and unilateral moyamoya disease is rare. We report herein an AVM patient...
Transient Increase in Intrathoracic Pressure as a Contributing Factor to Cardioembolic Stroke

Seok HY, Seo WK, Eun MY, Kwon DY, Park MH, Oh K

  • J Clin Neurol.
  • 2010 Dec;6(4):212-215.
  • doi: 10.3988/jcn.2010.6.4.212
BACKGROUND: The hemodynamic effects of increased intrathoracic pressure (ITP) have been the focus of many investigations. However, very little is known about the effects of elevated ITP on the occurrence...
Topographical Disorientation in Mild Cognitive Impairment: A Voxel-Based Morphometry Study

Lim TS, Iaria G, Moon SY

  • J Clin Neurol.
  • 2010 Dec;6(4):204-211.
  • doi: 10.3988/jcn.2010.6.4.204
BACKGROUND AND PURPOSE: To assess the neural substrates underlying topographical disorientation (TD) in patients affected by mild cognitive impairment (MCI), forty-one patients diagnosed with MCI and 24 healthy control individuals...
Measurement of Precuneal and Hippocampal Volumes Using Magnetic Resonance Volumetry in Alzheimer's Disease

Ryu SY, Kwon MJ, Lee SB, Yang DW, Kim TW, Song IU, Yang PS, Kim HJ, Lee AY

  • J Clin Neurol.
  • 2010 Dec;6(4):196-203.
  • doi: 10.3988/jcn.2010.6.4.196
BACKGROUND AND PURPOSE: Alzheimer's disease (AD) is associated with structural alterations in the medial temporal lobe (MTL) and functional alterations in the posterior cortical region, especially in the early stages....
Zonisamide Changes Unilateral Cortical Excitability in Focal Epilepsy Patients

Joo EY, Kim HJ, Lim YH, Ji KH, Hong SB

  • J Clin Neurol.
  • 2010 Dec;6(4):189-195.
  • doi: 10.3988/jcn.2010.6.4.189
BACKGROUND AND PURPOSE: To evaluate changes in cortical excitability induced by zonisamide (ZNS) in focal epilepsy patients. METHODS: Twenty-four drug-nasmall yi, Ukrainianve focal epilepsy patients (15 males; overall mean age 29.8...
Gender Differences in the Functional Recovery after Acute Stroke

Kim JS, Lee KB, Roh H, Ahn MY, Hwang HW

  • J Clin Neurol.
  • 2010 Dec;6(4):183-188.
  • doi: 10.3988/jcn.2010.6.4.183
BACKGROUND AND PURPOSE: PurposezzInterest in gender differences in the effects of acute stroke is growing worldwide. However, gender differences in functional recovery after acute stroke in the Korean population have...
Deep Brain Stimulation: Technology at the Cutting Edge

Shah RS, Chang SY, Min HK, Cho ZH, Blaha CD, Lee KH

  • J Clin Neurol.
  • 2010 Dec;6(4):167-182.
  • doi: 10.3988/jcn.2010.6.4.167
Deep brain stimulation (DBS) surgery has been performed in over 75,000 people worldwide, and has been shown to be an effective treatment for Parkinson's disease, tremor, dystonia, epilepsy, depression, Tourette's...
Seniors with Parkinson's Disease: Initial Medical Treatment

Ahlskog JE

  • J Clin Neurol.
  • 2010 Dec;6(4):159-166.
  • doi: 10.3988/jcn.2010.6.4.159
Parkinson's disease most often presents after age 60, and patients in this age group are best managed with levodopa therapy as the primary treatment modality. Unlike young-onset parkinsonism (onset

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: